470
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant

, , , , , & show all
Pages 680-687 | Received 17 Jan 2015, Accepted 20 Apr 2015, Published online: 15 May 2015

References

  • Aquino Esperanza JA, Aguirre MV, Aispuru GR, et al. In vivo 5-fluorouracil-[corrected]induced apoptosis on murine thymocytes: involvement of FAS, Bax and Caspase3. Cell Biol Toxicol 2008;24:411–422
  • Wang S, Konorev EA, Kotamraju S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem 2004;279:25535–25543
  • Safra T, Muggia F, Jeffers S, et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol 2000;11:1029–1033
  • Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011;63:131–135
  • Barenholz Y. Doxil(R) – the first FDA-approved nano-drug: lessons learned. J Control Release 2012;160:117–134
  • Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000;60:6950–6957
  • Shin J, Shum P, Thompson DH. Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release 2003;91:187–200
  • Huang SL, MacDonald RC. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 2004;1665:134–141
  • van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119–1125
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984;44:4721s–4730s
  • Oster G, Lamerato L, Glass AG, et al. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer 2013;21:3279–3286
  • Hung JY, Horn D, Woodruff K, et al. Colony-stimulating factor 1 potentiates lung cancer bone metastasis. Lab Invest 2014;94:371–381
  • Giger EV, Castagner B, Leroux JC. Biomedical applications of bisphosphonates. J Control Release 2013;167:175–188
  • Choi SW, Kim JH. Design of surface-modified poly(d,l-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007;122:24–30
  • Salerno M, Cenni E, Fotia C, et al. Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. Curr Cancer Drug Target 2010;10:649–659
  • Chen HY, Li GL, Chi HR, et al. Alendronate-conjugated amphiphilic hyperbranched polymer based on Boltorn H40 and poly(ethylene glycol) for bone-targeted drug delivery. Bioconjug Chem 2012;23:1915–1924
  • Anada T, Takeda Y, Honda Y, et al. Synthesis of calcium phosphate-binding liposome for drug delivery. Bioorg Med Chem Lett 2009;19:4148–4150
  • Hengst V, Oussoren C, Kissel T, Storm G. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm 2007;331:224–227
  • Wang G, Babadagli ME, Uludag H. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds. Mol Pharm 2011;8:1025–1034
  • Swami A, Reagan MR, Basto P, et al. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci USA 2014;111:10287–10292
  • Tagami T, Ernsting MJ, Li SD. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release 2011;154:290–297
  • Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release 2011;152:303–309
  • Jain A, Yan W, Miller KR, et al. Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity. Int J Pharm 2010;401:87–92
  • Patel JD, O'Carra R, Jones J, et al. Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens. Pharm Res 2007;24:343–352
  • Tang JL, Wang YJ, Wang D, et al. Key structure of Brij for overcoming multidrug resistance in cancer. Biomacromolecules 2013;14:424–430
  • Nilsson K, Mosbach K. Peptide synthesis in aqueous-organic solvent mixtures with alpha-chymotrypsin immobilized to tresyl chloride-activated agarose. Biotechnol Bioeng 1984;26:1146–1154
  • Niu G, Cogburn B, Hughes J. Preparation and characterization of doxorubicin liposomes. Cancer Nanotechnol 2010;624:211–219
  • Li L, ten Hagen TLM, Hossann M, et al. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release 2013;168:142–150
  • Gaber MH, Hong KL, Huang SK, Papahadjopoulos D. Thermosensitive sterically stabilized liposomes – formulation and in-vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm Res 1995;12:1407–1416
  • Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 2010;142:108–121
  • Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids 2005;135:117–129
  • Mastro AM, Vogler EA. A three-dimensional osteogenic tissue model for the study of metastatic tumor cell interactions with bone. Cancer Res 2009;69:4097–4100
  • Solomayer EF, Diel IJ, Meyberg GC, et al. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 2000;59:271–278
  • Fukuta K, Har-Shai Y, Collares MV, et al. Comparison of inorganic bovine bone mineral particles with porous hydroxyapatite granules and cranial bone dust in the reconstruction of full-thickness skull defect. J Craniofac Surg 1992;3:25–29
  • Gombotz WR, Wang GH, Horbett TA, Hoffman AS. Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res 1991;25:1547–1562
  • Bergstrom K, Holmberg K, Safranj A, et al. Reduction of fibrinogen adsorption on PEG-coated polystyrene surfaces. J Biomed Mater Res 1992;26:779–790
  • Szleifer I. Protein adsorption on surfaces with grafted polymers: a theoretical approach. Biophys J 1997;72:595–612
  • Xie J, Xu C, Kohler N, et al. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007;19:3163–3166
  • Dong X, Mumper RJ. The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. Drug Dev Ind Pharm 2006;32:973–980

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.